Parker Foundation Launches $250M Collaborative Institute for Cancer Immunotherapy

Jul

Exploring Tumor Tissue Architecture and Immune Response with Digital Spatial Profiling

Join this webinar to learn how spatial resolution of gene expression in tumor tissue reveals new insights in biomarker discovery and therapeutic response.

Jul

Featured Webinar

Clinical Utility of Liquid Biopsy for the Detection of T790M to Guide Lung Cancer Treatment Strategy

This webinar will discuss a study that set to assess the efficacy and safety of osimertinib in EGFR T790M positive non-small cell lung cancer (NSCLC) patients identified by using plasma sample and cobas EGFR Mutation test v2. This is the first prospective study to use liquid biopsy upfront to evaluate osimertinib efficacy.

Jul

Featured Webinar

Life Science Marketing Workshop: Creating a Go-To-Market Strategy in a Rapidly Evolving Sector

“If we build it, they will come” is a familiar refrain that echoes in life science entrepreneurial circles. Too frequently startups believe that if a technology is built it will sell.

Aug

Featured Webinar

Liquid Biopsy-based Molecular Risk Stratification of ALK-mutated Lung Cancer Patients

Non-small cell lung cancer (NSCLC) patients with ALK rearrangements are treated with tyrosine kinase inhibitors (TKIs), which often leads to prolonged overall survival. However, treatment resistance will almost inevitably occur, and the disease remains incurable.

Menu

Parker Foundation Launches $250M Collaborative Institute for Cancer Immunotherapy

To read the full story....

Breaking News

Sequencing Study Reveals Role of RIPOR2 Mutation in Adult-Onset Hearing Loss

Progenity Asks Court to Declare Non-Infringement of Natera Patents

FDA Issues New Guidance for SARS-CoV-2 Pooled Sample Testing

Computational Tools Help Predict Efficiency, Outcomes of Base Editors

Exome Analysis of Southwestern American Indians Highlights Metabolic Disease-Linked Variants

Advanced Biological Laboratories Gets CE Mark for SARS-CoV-2 qPCR Assay

Recent Headlines from
Precision Oncology News

Precision Oncology Trials Still Enroll Mostly White Patients Despite Initiatives, Calls to Diversify

GNS Healthcare, MMRF Bring Patient Simulations to Multiple Myeloma Precision Treatment, Trial Design

Merck's Second Tissue-Agnostic Approval for Keytruda Reignites TMB Cutoff Debate

Aprea's Drug for TP53-Mutant Cancers Moves Into Registrational Trials for Myelodysplastic Syndromes

Kinnate Exiting Stealth Mode With Plans to Move Lead RAF Inhibitor Into Clinical Trials Next Year

Featured White Papers

Exploring Tumor Tissue Architecture and Immune Response with Digital Spatial Profiling

Clinical Utility of Liquid Biopsy for the Detection of T790M to Guide Lung Cancer Treatment Strategy

Life Science Marketing Workshop: Creating a Go-To-Market Strategy in a Rapidly Evolving Sector

Liquid Biopsy-based Molecular Risk Stratification of ALK-mutated Lung Cancer Patients

What's Popular?

AnchorDx Demonstrates Liquid Biopsy DNA Methylation Test for Early Cancer Detection

Cancer AI Startup Nucleai Raises $6.5M in Series A Financing

Polygenic Risk Score Modifies Breast Cancer Risk in Pathogenic Variant Carriers

Cancer Research UK, Abcam Partner to Develop Custom Antibodies for Cancer Research

OncoCyte Downgraded to Neutral by Piper Sandler on Unsuccessful Results for Lung Cancer Test

Sponsorships